Salem Investment Counselors’s Biogen BIIB Stock Holding History

Salem Investment Counselors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$129K	Buy	599 +33	+6%	+$6.31K	﹤0.01%	461
2026 Q1	$104K	Buy	+566	New	+$104K	﹤0.01%	477
2025 Q4	–	Sell	-566	Closed	-$79.3K	–	473
2025 Q3	$79.3K	Hold	566	–	–	﹤0.01%	512
2025 Q2	$71.1K	Sell	566 -1	-0.2%	-$125	﹤0.01%	524
2025 Q1	$77.6K	Hold	567	–	–	﹤0.01%	495
2024 Q4	$86.7K	Hold	567	–	–	﹤0.01%	480
2024 Q3	$110K	Hold	567	–	–	﹤0.01%	444
2024 Q2	$131K	Sell	567 -91	-14%	-$19.8K	﹤0.01%	407
2024 Q1	$142K	Hold	658	–	–	﹤0.01%	404
2023 Q4	$170K	Buy	658 +50	+8%	+$12.3K	0.01%	369
2023 Q3	$156K	Buy	608 +1	+0.2%	+$267	0.01%	363
2023 Q2	$173K	Hold	607	–	–	0.01%	345
2023 Q1	$169K	Buy	607 +41	+7%	+$11.3K	0.01%	362
2022 Q4	$157K	Hold	566	–	–	0.01%	358
2022 Q3	$151K	Hold	566	–	–	0.01%	342
2022 Q2	$115K	Hold	566	–	–	0.01%	395
2022 Q1	$119K	Sell	566 -51	-8%	-$11.1K	﹤0.01%	398
2021 Q4	$148K	Buy	617 +592	+2,368%	+$152K	0.01%	404
2021 Q3	$7K	Hold	25	–	–	﹤0.01%	808
2021 Q2	$9K	Hold	25	–	–	﹤0.01%	725
2021 Q1	$7K	Sell	25 -1	-4%	-$270	﹤0.01%	719
2020 Q4	$6K	Sell	26 -71	-73%	-$18.3K	﹤0.01%	691
2020 Q3	$28K	Hold	97	–	–	﹤0.01%	449
2020 Q2	$26K	Hold	97	–	–	﹤0.01%	455
2020 Q1	$31K	Hold	97	–	–	﹤0.01%	389
2019 Q4	$29K	Buy	+97	New	+$26.9K	﹤0.01%	443
2017 Q3	–	Sell	-9	Closed	-$2K	–	572
2017 Q2	$2K	Buy	+9	New	+$2.38K	﹤0.01%	565

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Salem Investment Counselors's BIIB Position: Q2 2026 in Review

Salem Investment Counselors increased its Biogen (BIIB) stake by 5.8% in Q2 2026, buying an estimated $6.31K and bringing the position to 599 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Salem Investment Counselors first reported a position in BIIB in Q2 2017 and has held it in 27 quarters since. The position peaked at $173K in Q2 2023. 344 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Salem Investment Counselors held 599 shares of Biogen worth $129K as of Q2 2026.
Salem Investment Counselors bought 33 Biogen shares in Q2 2026, an estimated $6.31K.
Biogen made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #461 holding.
Salem Investment Counselors first reported a position in Biogen in Q2 2017 and has held it in 27 quarters since.
Salem Investment Counselors's Biogen position peaked at $173K in Q2 2023.
344 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.